Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice

Hsiu Chuan Yen, Terry D. Oberley, C. Gary Gairola, Luke I. Szweda, Daret K. St. Clair

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Adriamycin (ADR) is a potent anticancer drug that causes severe cardiomyopathy. We have previously demonstrated that ADR-induced ultrastructural mitochondrial injury in the heart was attenuated in manganese superoxide dismutase (MnSOD) transgenic mice. To further investigate the biochemical mechanisms by which MnSOD protected mitochondria against ADR- induced damage, cardiac mitochondrial function and activities were evaluated. The results showed that ADR caused significant decrease in state 3 respiration and respiratory control ratio using both complex I and II substrates in nontransgenic mice. In transgenic mice, state 3 respiration for complex I substrates remained unaffected by ADR, but was reduced for complex II substrate. Complex I activity was significantly decreased in nontransgenic, but not in transgenic mice after ADR treatment, suggesting that mitochondrial complex I is sensitive to inactivation by superoxide radicals. The activities of complex II and mitochondrial creatine kinase were decreased by ADR in both nontransgenic and transgenic mice. These results support our previous observations on the protective role of MnSOD on the ultrastructural damage of the heart after ADR treatment and extend the understanding of its mechanisms in mitochondria.

Original languageEnglish (US)
Pages (from-to)59-66
Number of pages8
JournalArchives of Biochemistry and Biophysics
Volume362
Issue number1
DOIs
StatePublished - Feb 1 1999

Fingerprint

Cardiomyopathies
Doxorubicin
Transgenic Mice
Superoxide Dismutase
Mitochondria
Respiration
Substrates
Mitochondrial Form Creatine Kinase
Heart Injuries
Superoxides
Pharmaceutical Preparations

Keywords

  • Adriamycin
  • Heart
  • Mitochondria
  • MnSOD

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology

Cite this

Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. / Yen, Hsiu Chuan; Oberley, Terry D.; Gairola, C. Gary; Szweda, Luke I.; St. Clair, Daret K.

In: Archives of Biochemistry and Biophysics, Vol. 362, No. 1, 01.02.1999, p. 59-66.

Research output: Contribution to journalArticle

Yen, Hsiu Chuan ; Oberley, Terry D. ; Gairola, C. Gary ; Szweda, Luke I. ; St. Clair, Daret K. / Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. In: Archives of Biochemistry and Biophysics. 1999 ; Vol. 362, No. 1. pp. 59-66.
@article{7659bb313190450a94bb8794162bd250,
title = "Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice",
abstract = "Adriamycin (ADR) is a potent anticancer drug that causes severe cardiomyopathy. We have previously demonstrated that ADR-induced ultrastructural mitochondrial injury in the heart was attenuated in manganese superoxide dismutase (MnSOD) transgenic mice. To further investigate the biochemical mechanisms by which MnSOD protected mitochondria against ADR- induced damage, cardiac mitochondrial function and activities were evaluated. The results showed that ADR caused significant decrease in state 3 respiration and respiratory control ratio using both complex I and II substrates in nontransgenic mice. In transgenic mice, state 3 respiration for complex I substrates remained unaffected by ADR, but was reduced for complex II substrate. Complex I activity was significantly decreased in nontransgenic, but not in transgenic mice after ADR treatment, suggesting that mitochondrial complex I is sensitive to inactivation by superoxide radicals. The activities of complex II and mitochondrial creatine kinase were decreased by ADR in both nontransgenic and transgenic mice. These results support our previous observations on the protective role of MnSOD on the ultrastructural damage of the heart after ADR treatment and extend the understanding of its mechanisms in mitochondria.",
keywords = "Adriamycin, Heart, Mitochondria, MnSOD",
author = "Yen, {Hsiu Chuan} and Oberley, {Terry D.} and Gairola, {C. Gary} and Szweda, {Luke I.} and {St. Clair}, {Daret K.}",
year = "1999",
month = "2",
day = "1",
doi = "10.1006/abbi.1998.1011",
language = "English (US)",
volume = "362",
pages = "59--66",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice

AU - Yen, Hsiu Chuan

AU - Oberley, Terry D.

AU - Gairola, C. Gary

AU - Szweda, Luke I.

AU - St. Clair, Daret K.

PY - 1999/2/1

Y1 - 1999/2/1

N2 - Adriamycin (ADR) is a potent anticancer drug that causes severe cardiomyopathy. We have previously demonstrated that ADR-induced ultrastructural mitochondrial injury in the heart was attenuated in manganese superoxide dismutase (MnSOD) transgenic mice. To further investigate the biochemical mechanisms by which MnSOD protected mitochondria against ADR- induced damage, cardiac mitochondrial function and activities were evaluated. The results showed that ADR caused significant decrease in state 3 respiration and respiratory control ratio using both complex I and II substrates in nontransgenic mice. In transgenic mice, state 3 respiration for complex I substrates remained unaffected by ADR, but was reduced for complex II substrate. Complex I activity was significantly decreased in nontransgenic, but not in transgenic mice after ADR treatment, suggesting that mitochondrial complex I is sensitive to inactivation by superoxide radicals. The activities of complex II and mitochondrial creatine kinase were decreased by ADR in both nontransgenic and transgenic mice. These results support our previous observations on the protective role of MnSOD on the ultrastructural damage of the heart after ADR treatment and extend the understanding of its mechanisms in mitochondria.

AB - Adriamycin (ADR) is a potent anticancer drug that causes severe cardiomyopathy. We have previously demonstrated that ADR-induced ultrastructural mitochondrial injury in the heart was attenuated in manganese superoxide dismutase (MnSOD) transgenic mice. To further investigate the biochemical mechanisms by which MnSOD protected mitochondria against ADR- induced damage, cardiac mitochondrial function and activities were evaluated. The results showed that ADR caused significant decrease in state 3 respiration and respiratory control ratio using both complex I and II substrates in nontransgenic mice. In transgenic mice, state 3 respiration for complex I substrates remained unaffected by ADR, but was reduced for complex II substrate. Complex I activity was significantly decreased in nontransgenic, but not in transgenic mice after ADR treatment, suggesting that mitochondrial complex I is sensitive to inactivation by superoxide radicals. The activities of complex II and mitochondrial creatine kinase were decreased by ADR in both nontransgenic and transgenic mice. These results support our previous observations on the protective role of MnSOD on the ultrastructural damage of the heart after ADR treatment and extend the understanding of its mechanisms in mitochondria.

KW - Adriamycin

KW - Heart

KW - Mitochondria

KW - MnSOD

UR - http://www.scopus.com/inward/record.url?scp=0033080175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033080175&partnerID=8YFLogxK

U2 - 10.1006/abbi.1998.1011

DO - 10.1006/abbi.1998.1011

M3 - Article

C2 - 9917329

AN - SCOPUS:0033080175

VL - 362

SP - 59

EP - 66

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

IS - 1

ER -